These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28446142)

  • 21. Autoantibodies against vinculin in patients with chronic inflammatory demyelinating polyneuropathy.
    Beppu M; Sawai S; Satoh M; Mori M; Kazami T; Misawa S; Shibuya K; Ishibashi M; Sogawa K; Kado S; Kodera Y; Nomura F; Kuwabara S
    J Neuroimmunol; 2015 Oct; 287():9-15. PubMed ID: 26439954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go.
    Nobile-Orazio E
    J Peripher Nerv Syst; 2014 Mar; 19(1):2-13. PubMed ID: 24612201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal Fluid Cytokine Expression Profile in Multiple Sclerosis and Chronic Inflammatory Demyelinating Polyneuropathy.
    Bonin S; Zanotta N; Sartori A; Bratina A; Manganotti P; Trevisan G; Comar M
    Immunol Invest; 2018 Feb; 47(2):135-145. PubMed ID: 29182448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Zhang HL; Zhang XM; Mao XJ; Deng H; Li HF; Press R; Fredrikson S; Zhu J
    Acta Neurol Scand; 2012 Feb; 125(2):129-35. PubMed ID: 21434877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary?
    Wadwekar V; Kalita J; Misra UK
    Neurol India; 2011; 59(5):664-8. PubMed ID: 22019647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated serum levels of endothelin-1 in patients with chronic inflammatory demyelinating polyneuropathy.
    Chang CW; Wu HC; Lyu RK; Lo YS; Chen CM; Ro LS; Chang HS; Huang CC; Liao MF; Wu YR; Kuo HC; Chu CC; Weng YC; Wei PT; Lo AL; Chang KH
    Clin Chim Acta; 2018 Jan; 476():49-53. PubMed ID: 29137897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunopathology and treatments of Guillain-Barré syndrome and of chronic inflammatory demyelinating polyneuropathy].
    Radziwill AJ; Kuntzer T; Steck AJ
    Rev Neurol (Paris); 2002 Mar; 158(3):301-10. PubMed ID: 11976589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fas-mediated T-cell apoptosis is impaired in patients with chronic inflammatory demyelinating polyneuropathy.
    Comi C; Gaviani P; Leone M; Ferretti M; Castelli L; Mesturini R; Ubezio G; Chiocchetti A; Osio M; Muscia F; Bogliun G; Corso G; Gavazzi A; Mariani C; Cantello R; Monaco F; Dianzani U
    J Peripher Nerv Syst; 2006 Mar; 11(1):53-60. PubMed ID: 16519782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of 2-limb versus 3-limb electrodiagnostic studies in the evaluation of chronic inflammatory demyelinating polyneuropathy.
    Vo ML; Hanineva A; Chin RL; Carey BT; Latov N; Langsdorf JA
    Muscle Nerve; 2015 Apr; 51(4):549-53. PubMed ID: 25131219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype.
    Mathey EK; Park SB; Hughes RA; Pollard JD; Armati PJ; Barnett MH; Taylor BV; Dyck PJ; Kiernan MC; Lin CS
    J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):973-85. PubMed ID: 25677463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD8+ T-cell immunity in chronic inflammatory demyelinating polyradiculoneuropathy.
    Schneider-Hohendorf T; Schwab N; Uçeyler N; Göbel K; Sommer C; Wiendl H
    Neurology; 2012 Feb; 78(6):402-8. PubMed ID: 22238416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The immune response and aging in chronic inflammatory demyelinating polyradiculoneuropathy.
    Hagen KM; Ousman SS
    J Neuroinflammation; 2021 Mar; 18(1):78. PubMed ID: 33752693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relapsing demyelinating disease affecting both the central and peripheral nervous systems.
    Zéphir H; Stojkovic T; Latour P; Lacour A; de Seze J; Outteryck O; Maurage CA; Monpeurt C; Chatelet P; Ovelacq E; Vermersch P
    J Neurol Neurosurg Psychiatry; 2008 Sep; 79(9):1032-9. PubMed ID: 18208860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic inflammatory demyelinating polyneuropathy (CIDP): change of serum IgG dimer levels during treatment with intravenous immunoglobulins.
    Ritter C; Bobylev I; Lehmann HC
    J Neuroinflammation; 2015 Aug; 12():148. PubMed ID: 26268846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15.
    Martinez-Martinez L; Lleixà MC; Boera-Carnicero G; Cortese A; Devaux J; Siles A; Rajabally Y; Martinez-Piñeiro A; Carvajal A; Pardo J; Delmont E; Attarian S; Diaz-Manera J; Callegari I; Marchioni E; Franciotta D; Benedetti L; Lauria G; de la Calle Martin O; Juárez C; Illa I; Querol L
    J Neuroinflammation; 2017 Nov; 14(1):224. PubMed ID: 29145880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic inflammatory demyelinating polyneuropathy.
    Lewis RA
    Curr Opin Neurol; 2017 Oct; 30(5):508-512. PubMed ID: 28763304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum cytokine and chemokine profiles in patients with chronic inflammatory demyelinating polyneuropathy.
    Beppu M; Sawai S; Misawa S; Sogawa K; Mori M; Ishige T; Satoh M; Nomura F; Kuwabara S
    J Neuroimmunol; 2015 Feb; 279():7-10. PubMed ID: 25669993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical features of CIDP with LM1-associated antibodies.
    Kuwahara M; Suzuki H; Samukawa M; Hamada Y; Takada K; Kusunoki S
    J Neurol Neurosurg Psychiatry; 2013 May; 84(5):573-5. PubMed ID: 23138763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Kuwahara M; Suzuki S; Takada K; Kusunoki S
    J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy.
    Yan WX; Archelos JJ; Hartung HP; Pollard JD
    Ann Neurol; 2001 Sep; 50(3):286-92. PubMed ID: 11558784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.